Background: Gamma-irradiation of leukoreduced red blood cells (RBCs) prevents transfusion-associated graft-versus-host disease, but it also exacerbates 'storage lesion' formation in RBCs. We hypothesized that storage after irradiation decreases the oxygen delivery capacity of transfused RBCs in anaemic preterm infants.
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Methods: Sixty-four non-urgent transfusion episodes in 47 preterm infants (<34 weeks gestation) were studied in Wellington NICU. Transfusion episodes were randomised to the intervention (RBC irradiated on the day of transfusion, n = 32) or control arm (RBCs irradiated and stored as per the ANZSBT guidelines, n = 32). Cerebral regional oxygenation (crSO 2 ) and fractional tissue oxygen extraction (FTOE) were studied by blinded clinicians using Near Infrared Spectroscopy (Sensmart X-100, Nonin) for 3hrs immediately before, immediately after, 1 and 5 days after transfusion.
Results: We observed a significant increase in crSO 2 (77.4% vs 79.8%, P < 0.001) and decrease in FTOE (0.15 vs 0.12, P < 0.01) immediately after transfusion in infants who received freshly irradiated RBCs. These effects were sustained up to 5 days after transfusion. There was no difference in crSO 2 or FTOE in infants who received irradiated and stored RBCs (8 AE 4 days) at any of the time points.
Conclusions: Our findings indicate that storage after gammairradiation has a detrimental effect on the oxygen delivery capacity of transfused RBCs. Further research is required to investigate the safety and efficacy of RBCs prepared as per the ANZSBT guidelines for preterm infants. The published rate of congenital fetal abnormalities in women with pre-existing diabetes is 3.5-5%
THE RISK OF CONGENITAL ABNORMALITY IN THE DIABETIC PREGNANT POPULATION IN ONE TERTIARY REFERRAL CENTRE
1 . Our unit provides tertiary level obstetric care to a diabetes population from across the state of Western Australia, including via the use of telemedicine healthcare provision from specialist diabetes education midwives. The rate of congenital fetal anomalies in our population has not previously been investigated. We sought to quantify the risk to our population in order to provide accurate information and targeted diabetes control advice. Method: All patients with pre-existing Type 1 and Type 2 diabetes mellitus under the care of the King Edward Memorial Hospital diabetes clinic between 2007 and 2017 were included. Patients who had not had an anomaly scan in our unit were excluded. Patient records were reviewed and data analysis undertaken.
Results: Approximately 1000 patients are included in the study. Data analysis is underway and will be ready to present at PSANZ 2019. Early analysis suggests our population has a similar congenital abnormality rate to the previously published literature.
Conclusions: Optimisation of diabetic control is likely to result in improved perinatal outcomes. Further research is required to elucidate the relative risk of fetal congenital abnormality in relation to peri-conception diabetes control and to design effective patient education packages around the issue of peri-conception health optimisation in this population.
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